Nov 15 & 16Boston#STATSummit Register nowView Speakers About From trials to triumph: healing medicine's ailments A multi-year pandemic has brought no end of trials, but also plenty of triumphs. Come for a silo-breaking and solution-focused discussion of the most important topics in health care with some of the industry's greatest minds. Join the program virtually,…
Four health care leaders took the stage at the STAT Health Tech Summit in San Francisco to pitch their ideas for transforming health care.
2022 STAT Health Tech Summit will feature MacArthur Award winner Joshua Miele and Google Chief Health Officer Karen DeSalvo BOSTON, MA – Today, STAT, the nation’s must-read health, science, and medicine publication, is proud to announce its 2022 Health Tech Summit. The one day, in-person event will take place on May 24, 2022, in San…
READ About Summit About The 2022 STAT Health Tech Summit is complete Thank you to the speakers and everyone who tuned into - and contributed to - this event. Be sure to catch up on key moments from the event. Meet us at the convergence of biology and technology The pandemic turned out to be…
In the latest edition of STAT Health Tech: how to train your AI to predict bad outcomes, the ripple effects of privacy laws, and digital health's notable leaders.
The former Stanford computer science professor received global acclaim as a co-founder of online education company Coursera. But these days, health care occupies most of her time. She founded Insitro in 2018 — reportedly the first company to base all of its drug discovery on AI. Last March, the South San Francisco startup announced $400…
"Coming from tech, I’m used to big data problems with billions of users," said Insitro's Tom Stocky. "In biology, a lot of it is small data problems."
Companies that promise to speed up pharmaceutical development with algorithms are raking in enormous investments.
“The hardest part of drug discovery and development... is picking targets,” Perlmutter said. "And picking targets is at this point is largely an intuitive process."
If money keeps flowing to big names in the economic crisis, it could have stark consequences, with smaller companies struggling for crumbs as their larger competitors grab bigger pieces of the pie.
A star scientist in the world of single-cell genomics and computational biology is leaving academia to become one of the few women leading R&D at a biotech company.
VC firm Andreessen Horowitz once pledged to never invest in health care. Now it's launching its third life sciences fund.
An explosion of biological data will lead to the first drug candidates discovered by an artificial-intelligence system within the next few years, experts predicted. #STATsummit
AI startups are racing into drug development. Here’s five burning questions about which will survive.
From CRISPR to machine learning, how tech is reinventing how medicines are made.
In science, the line between academia and industry used to be clear. No longer.
Nov 20 & 21Cambridge, MA#STATSUMMIT About Catalyzing a revolution in human health Biology is changing the world. For almost four years, STAT has been reporting from the frontiers of medicine like no other publication. Now, Matthew Herper, Editorial Director of Events, and the rest of the STAT team are assembling top executives and researchers, policymakers,…
The founder of the online education company Coursera is making a big bet on AI in drug development — and got the attention of big drug maker Gilead.
How much do doctors need to understand how a computer reaches a health care decision? That debate played out during an #artificialintelligence conference this week.
AbbVie and Google parent company Alphabet announce they are each committing $500 million to continue funding the scientists researching aging at the ambitious Alphabet unit called Calico.
Up-and-coming biotech CEOs are making the pilgrimage to Menlo Park, Calif., for an all-important 50-minute meeting with Andreessen Horowitz.
